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Background: Fatal human critical cases associated with influenza A
subtype H5N1 have been documented in Bandung, Indonesia. Of four
children, three died. We determined the level of cytokines and chemokines
in those patients.
Methods: The Luminex method was used to look for the profile of
cytokine and chemokine gene expression induced by H5N1 influenza virus
from patient’s serum.
Results: We found that H5N1 influenza virus in the dead children was a
more potent inducer of IL-6, the level being higher (17.00, 74.31, 85.75)
than in the one child who survived (4.78). The IFNg level of the fatal
causes was also higher (21.43, 31.75, 384.38) than in the one child who
recovered (5.51). This suggested that a cytokine storm may play a role in
the pathogenesis of fatal H5N1 cases.
Conclusion: The H5N1 influenza A virus is a potent inducer of
proinflammatory cytokines and chemokines. This hyperinduction of
cytokines may be relevant to mortality of children with H5N1 infection.
P54
Abstract withdrawn
Critical Care 2012, 16(Suppl 3):P54
P55
Involvement of thrombopoietin in the development of organ injury
in a mouse model of cecal ligation and puncture-induced sepsis
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G Montrucchio
University of Turin, Italy
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Background: Sepsis-induced organ damage is a leading cause of death in
critically ill patients. Thrombopoietin (TPO) is a humoral growth factor
mainly involved in regulation of platelet number and function. High
circulating levels of TPO are detectable in septic adults and children and
are related to sepsis severity. We have previously shown a correlation
between TPO levels and platelet activation in septic burned patients,
where circulating activated platelets may cause microthrombotic events
that lead to organ damage. Our aim was to evaluate the contribution of
TPO in organ injury in a murine model of polymicrobial sepsis. To this end,
we synthesized and used a chimeric fusion protein, named mouse TPO
Receptor-Maltose Binding Protein (mTPOR-MBP), able to inhibit TPO
biological activity.
Methods: Male C57BL/6 mice were randomized to cecal ligation and
puncture-induced sepsis (CLP) or to laparotomy (sham) surgery. CLP mice
received 40 μg mTPO-MBP or sterile saline 10 minutes after surgery.
Immediately after and 6 hours after surgery all animals received 0.08 mg/kg
buprenorfin in 1.5 ml sterile saline subcutaneously. After 18 hours blood was
collected from the cava vein and used for cell count, flow cytometric
analysis of leukocyte-platelet interaction and to obtain plasma. Plasma TPO
levels were determined by ELISA. The lung and liver were excised and fixed
in 4% paraformaldehyde solution. An expert pathologist blinded to
experimental groups quantified organ damage.
Results: Plasma TPO levels were significantly higher in septic mice (nine
mice in each group). Leukocyte and platelet counts did not significantly
differ in the CLP group treated with mTPOR-MBP compared with the CLP
control group. In contrast, the percentage of monocyte-platelet
aggregates, a marker of platelet activation, was significantly reduced after
treatment with mTPOR-MBP. Moreover, TPO blockade by mTPOR-MBP
administration induced a significant reduction of histological alterations
in the lung, as evaluated by neutrophil infiltration and thickening of the
alveolar-capillary membrane, and liver tissue samples, as evaluated by the
number of microabscesses.
Conclusion: Increased circulating levels of TPO during experimental
sepsis may have a role in the development of organ damage. Inhibition
of TPO biological activity may represent a novel promising therapeutic
approach to prevent organ failure in severe sepsis.
P56
Cholecystokinin protects rats against Staphylococcus aureus-induced
sepsis
RS Saia*, FMC Zuelli, EC Cárnio
University of Sao Paulo, Ribeirão Preto, São Paulo, Brazil
Critical Care 2012, 16(Suppl 3):P56
Background: Cholecystokinin (CCK) was firstly described as a
gastrointestinal hormone, but immune cells express their receptors,
suggesting a possible involvement of this peptide in pathophysiological
processes. Our aims were to evaluate the role of CCK on resistance against
Gram-positive Staphylococcus aureus-induced sepsis, as well as cell influx to
infectious focus. Furthermore, since nitric oxide, TNFa and IL-10 play a key
role in the innate immune system controlling bacterial infection, we also
evaluated the synthesis of these inflammatory mediators during this sepsis
model.
Methods: Male Wistar rats (180 to 200 g) received an intraperitoneal
injection of proglumide (P) (nonselective CCK receptor antagonist; 30 or
50 mg/kg) 30 minutes before bacterial S. aureus inoculum (0.5 to 1 × 1010
CFU/animal). At 4 and 24 hours after sepsis induction, blood and
peritoneal lavage fluid (PLF) were collected for microbiological analysis,
cytokines and nitrate quantifications and also differential cell counting.
Nitrate was detected by chemiluminescence, while TNFa and IL-10 were
determined by ELISA sandwich kits.
Results: The pretreatment with P at higher dose (50 mg/kg) increased
bacteremia in comparison with the saline-injected group (2,052 ± 810.7
vs. 154.3 ± 47.0 CFU/ml, P < 0.01) at 4 hours after sepsis induction. At the
same time point, the bacterial counting in PLF increased in a dose-
dependent manner in the P-treated rats (P < 0.05). On the other hand,
only the higher P dose elevated significantly the CFU/ml in the PLF at
24 hours (97.75 ± 12.77 × 104 vs. 35 ± 10.05 × 104 CFU/ml, P < 0.05). The
plasma TNFa and nitrate concentrations were not changed by treatment
or time after sepsis induction. However, the administration of CCK
receptors antagonist reduced the TNFa production in comparison with
the control group in PLF, at both time points. The plasma IL-10
concentration increased at 4 hours in P-treated rats, while at 24 hours it
was reduced (85.83 ± 48.0 vs. 1,698 ± 265.6 pg/ml, P < 0.001). In PLF, the
rats pretreated with P reduced the IL-10 measurements (P < 0.05) when
compared with the control group. In agreement, the macrophage influx
to peritoneal infectious focus was compromised by treatment with a high
P dose at 24 hours after S. aureus-induced sepsis (3,947.73 ± 269.99 vs.
5,629.61 ± 786.90 cells/μl; P < 0.05). Moreover, the neutrophil count did
not change among the experimental groups (6,860.59 ± 211.90 vs.
6,273.54 ± 798.91 cells/μl).
Conclusion: These data suggest a protective role for CCK peptide during
S. aureus-induced sepsis, modulating the systemic and local inflammatory
response, as well as increasing the macrophage influx to the infectious
focus.
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delivery in septic patients
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Background: Since 1994, Polymyxin B-direct hemoperfusion (PMX-DHP)
(Toraymyxin®; Toray Medical Co., Tokyo, Japan) has been approved as
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a therapy for patients with severe sepsis or septic shock due to Gram-
negative infection in Japan. However, its efficacy and indication are still
controversial issues. Recently, randomized controlled studies are ongoing
in other countries. Our hypothesis is that PMX-DHP therapy may improve
the hemodynamic status in septic patients.
Methods: From July 1994 to June 2010, all adult patients treated with
PMX-DHP and receiving a pulmonary arterial catheter (PAC) in our ICU
were included in this retrospective observational study. Patients’ clinical,
microbiological and PAC data were collected from medical archives. PAC
variables were compared between immediately before and immediately
after PMX-DHP therapy. Values were expressed as mean ± SD. Data were
analyzed by Wilcoxon signed-ranks test, chi-square test and Fisher’s exact
probability test. P < 0.05 was considered statistically significant.
Results: Sixty-three patients (36 men, 27 women; age range 24 to
89 years (mean 63.4 ± 14.8)) were studied. The mortality rate was 30.2%
at 28 days after PMX-DHP. The APACHE II score and SOFA score on the
day of PMX-DHP therapy were 20.2 ± 14.8 and 7.3 ± 3.8, respectively.
Mean arterial pressure (MAP; mmHg), cardiac index (CI; l/minute/m2), and
oxygen delivery and consumption (DO2 and VO2; ml/minute) significantly
improved after PMX-DHP therapy (77.5 ± 22.5 vs. 84.1 ± 23.4, P = 0.0013;
3.9 ± 1.5 vs. 4.3 ± 1.2, P = 0.0006; 951.6 ± 403.5 vs. 1,002.5 ± 394.0, P =
0.013; 233.5 ± 80.6 vs. 248.0 ± 84.1, P = 0.004, respectively). The systemic
venous resistance index (SVRI) (dyn second m2/cm5) and mixed venous
oxygen saturation (SvO2; %) were not statistically different before and
after PMX-DHP therapy (1,573.6 ± 614.6 vs. 1,527.7 ± 575.5, P = 0.069;
71.9 ± 9.0 vs. 74.1 ± 7.5, P = 0.082). The inotropic score and P/F ratio
improved after the therapy (9.9 ± 15.9 vs. 7.5 ± 12.5, P = 0.018; 269.8 ±
108.5 vs. 300.6 ± 133.4, P = 0.003).
Conclusion: MAP, CI, DO2, VO2, inotropic score and P/F ratio improved
after PMX-DHP therapy, while SVRI and SVO2 did not change. PMX-DHP
could contribute to oxygen delivery due to improve hemodynamic status,
while decreasing inotropic agents in septic patients.
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Sepsis in neonates: experience in a tertiary-care hospital
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Background: Sepsis is a common condition in newborns, which has
significant morbidity and mortality worldwide. In recent years, multiple
factors have led to an increase in its incidence, such as the use of invasive
diagnostic procedures, broad-spectrum antimicrobial therapy and an
increase of immunocompromised patients. There have also been changes
in the profile of the agents causing sepsis. The aims of this study were the
determination of the annual incidence of neonatal sepsis (early-onset and
late-onset), analyzing their clinical course, significant microorganisms
isolated and the profile of antimicrobial resistance.
Methods: One hundred and ninety-eight cases of sepsis were studied,
collected over the past five years (2007 to 2011). Early-onset neonatal
sepsis was defined as that which appeared before 3 days of life and late-
onset neonatal sepsis if it happened later. Blood cultures were incubated
in the BACTEC FX System (Becton Dickinson), and identification and
antimicrobial susceptibility testing were done by the Wider system (Soria
Melguizo). Yeasts were identified by ID32C (bioMerieux).
Results: Of the 198 detected sepsis cases, 173 (87.4%) were late and 25
(12.6%) were early. While the annual incidence rate of early-onset sepsis
was uniform in each year, the late-onset sepsis has experienced an
increase in 2011. The mortality rate was similar throughout the study
(10.8%). Gram-negative bacilli are the most frequently isolated (48%),
with predominance of enterobacteria compared with nonfermenters (84
vs. 11 cases), followed by Gram-positive cocci (36%) and yeast (16%).
In candidemia most common are nonalbicans species of Candida (27 vs.
5 cases), with Candida parapsilosis more frequently isolated (65.6%).
Klebsiella pneumoniae (33 strains) was the more frequent microorganism,
followed by Escherichia coli, Staphylococcus epidermidis, C. parapsilosis and
Enterobacter cloacae. With respect to antibiotic resistance, 11.1% of
Staphylococcus aureus were MRSA and 19% (16 strains) of enterobacteria
were ESBL producing. Only one strain of Pseudomonas aeruginosa was
resistant to imipenem by metallobetalactamases.
Conclusion: K. pneumoniae was the organism responsible for more
episodes of sepsis in neonates. As in other studies in neonatology, this
study highlights the prevalence of nonalbicans species in candidemia due
to the frequency of C. parapsilosis. Late-onset sepsis has increased by
Gram-negative bacilli in the last year, probably due to the occurrence of
a nosocomial outbreak of ESBL-producing E. cloacae. However, the
mortality rate from sepsis has remained stable. When clinically evaluated,
cases of sepsis can be detected as a predominance of enterobacteria
against S. epidermidis, highlighting the importance of careful analysis of
clinical outcomes.
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Background: Kidney injury molecule-1 (KIM-1) is a new biomarker
promising a better detection and diagnostic quality of acute kidney injury
(AKI).
Methods: This clinical prospective study - approved by the local ethics
committee - was performed to assess urinary levels of KIM-1 by ELISA
technique in 38 patients with septic shock (Table 1). They were prospectively
enrolled within 24 hours of onset of signs of infection, if they met the criteria
for septic shock as defined by the members of the ACCP/SCCM Consensus
Conference Committee. KIM-1 levels were quantified on admission (baseline,
day 0) and on days 4, 7 and 10 of the ICU stay. The patients were classified
by AKIN and RIFLE criteria. Data were analyzed with regard to the prognostic
value of survival, need for renal replacement therapy (RRT) and correlation
with renal function parameters (plasmatic urea and creatinine, creatinine
elimination and clearance, free water clearance, fractional sodium excretion)
or hepatic laboratory findings (albumin, total bilirubin, ASAT, ALAT, g-GT).
Data are given as mean ± SEM.
Results: The urinary KIM-1 concentration on admission showed no
significant difference with respect to survival of patients. However, the
urinary KIM-1 concentration determined on days 4, 7 and 10 was higher in
patients surviving septic shock (P < 0.001 on days 4 and 7). Elimination
displayed lower levels in deceased patients (P < 0.05 on days 0 and 4),
whereas urinary output was higher in survivors during the whole ICU stay
(P < 0.05 on day 7). Urinary KIM-1 concentration did not differ between AKIN
and RIFLE classification groups. Urinary KIM-1 elimination per 24 hours on
days 0, 4 and 7 was higher in stage 1 than in stage 2 or 3 of the AKIN
classification, respectively (both P < 0.05). If patients were classified by RIFLE
criteria, urinary KIM-1 elimination was also higher in the risk group as
compared with the injury or failure group without reaching significance.
However, the need for RRT was reflected by a higher urinary KIM-1
concentration after admission (P < 0.05 on days 4 and 10), a lower KIM-1
elimination and urinary output during the whole ICU stay (KIM-1 elimination:
Table 1(abstract P59) Demographic data
Age (years) 57.2 ± 2.6
Gender (male/female) 27/11
BMI (kg/m2) 29.7 ± 1.5
Length of ICU stay (days) 19.5 ± 2.7
Mortality (%) 13.2 (5 out of 38 patients)
SAPS score 63.4 ± 2.7
APACHE II score 28.8 ± 1.3
SOFA score 12.7 ± 0.5
MOD score 10.4 ± 0.6
RIFLE (number per group) no AKI = 28; risk = 4; injury = 3;
failure = 3;
AKIN (number per group) no AKI = 25; stage 1 = 1; stage 2 = 1;
stage 3 = 11
Need for RRT (yes/no) 16/22
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